Detalhe da pesquisa
1.
A multicentre analytical comparison study of inter-reader and inter-assay agreement of four programmed death-ligand 1 immunohistochemistry assays for scoring in triple-negative breast cancer.
Histopathology
; 78(4): 567-577, 2021 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-32936950
2.
Comprehensive analysis of fibroblast activation protein expression across 23 tumor indications: insights for biomarker development in cancer immunotherapies.
Front Immunol
; 15: 1352615, 2024.
Artigo
em Inglês
| MEDLINE | ID: mdl-38558814
3.
Multicentric Analytical and Inter-observer Comparability of Four Clinically Developed Programmed Death-ligand 1 Immunohistochemistry Assays in Advanced Clear-cell Renal Cell Carcinoma.
Clin Genitourin Cancer
; 18(5): e629-e642, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32178978